For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
0
views
18
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      155
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Development of regional pharmacy intravenous admixture services data reporting and analysis platform for enhanced quality control ability

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Pharmacy intravenous admixture service (PIVAS) center has emerged as an important department of hospitals as it can improve occupational protection and ensure the safety and effectiveness of intravenous infusions. However, there is little research on the standardized capability and risk evaluation of PIVAS by using modern information technology. In this research, we established Regional Pharmacy Intravenous Admixture Services Data Reporting and Analysis Platform (RPDRAP) to improve quality control ability for PIVAS management. RPDRAP including evaluation matrix for quality control monitoring. The construction of platform is based on guidelines for the Construction and Management of PIVAS and management specifications of PIVAS in China.

          Methods

          RPDRAP was established in 2018. This platform comprises a data collection system and a data analysis system. The data collection system consists of 67 data items. Data collection relied on online platforms through data acquisition module. The collected data were analyzed using a model with 20 indicators within the data analysis system. Fifteen hospitals, public comprehensive healthcare facilities with more than 500 beds, participated in the platform’s application evaluation.

          Results

          The study revealed significant differences in PIVAS total score, supervisors, and workload between 2020 and 2022. The platform’s application results demonstrated improvements in personnel management, work efficiency, and infection control within these PIVAS. Although statistical significance was observed in only 8 out of the 25 items, most of the scores showed an increase, with a small portion remaining unchanged and no decline in scores.

          Conclusions

          This platform can be recommended for PIVAS homogeneous and regional efficient management. The use of this platform not only improves the quality control ability of PIVAS but also enables the management department to quickly grasp the current situation and characteristics of each PIVAS through standardized data collection and analysis.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical review: Medication errors in critical care

          Eric Moyen, Eric Camiré, Henry Thomas Stelfox (2008)
          Medication errors in critical care are frequent, serious, and predictable. Critically ill patients are prescribed twice as many medications as patients outside of the intensive care unit (ICU) and nearly all will suffer a potentially life-threatening error at some point during their stay. The aim of this article is to provide a basic review of medication errors in the ICU, identify risk factors for medication errors, and suggest strategies to prevent errors and manage their consequences.
          Article 0 comments Cited 68 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Short-term Peripheral Venous Catheter–Related Bloodstream Infections: A Systematic Review

            Leonard A. Mermel (2017)
            Article 0 comments Cited 56 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Virtual Pharmacist Interventions on Abuse/Misuse of Over-the-Counter Medications during COVID-19 versus Traditional Pharmacist Interventions

              Nadia Al Mazrouei, Rana M. Ibrahim, Ahmad Al Meslamani … (2021)
              Objective This study aimed to investigate frequency, nature, and clinical significance of pharmacist interventions on Over-the-Counter (OTC)medicines with abuse potential across community pharmacies with and without virtual care. Materials and Methods In this prospective observational study, a trained research team observed the dispensary team of 12 community pharmacies in the UAE, of which 6 were operating virtual pharmacy care. A standardized data collection form was used to include information about dispensing of OTC medicines and pharmacist interventions on those with abuse/misuse potential. Clinical significance of interventions was evaluated by a multidisciplinary committee. Results The Frequency of pharmacist interventions on OTC medicines with abuse potential across pharmacies with and without virtual services was 83.2% versus 91.0%. While the Frequency of pharmacist interventions on OTC medicines with misuse potential across pharmacies with and without virtual services was 79.8% versus 41.2%. The proportions of significant interventions across pharmacies with and without virtual services were 19.7% versus 10.5%. Cough medicines were dispensed significantly more across pharmacies with virtual care (25.6% vs 9.7%, p=0.04). Asking the patient to seek the advice of addiction specialist (adjusted odds ratio (AOR) = 4.11; p=0.001) versus refusing to sell the drug were more likely to be associated with pharmacies with virtual services versus pharmacies operating traditional pharmacy services. Discussion The use of information technology tools in pharmacy settings enabled the pharmacists to intervene on OTC medicines with misuse potential, but limited their ability to detect potential OTC abusing due to absence of physical contact with the patients. Conclusion Virtual pharmaceutical care is a potential approach to reduce OTC medicines abusing/misusing, but needs some improvements regarding detection of these cases. The UAE is the first country in the region to implement and regulate virtual pharmacy practice.
              Article 0 comments Cited 10 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Contributors
                Fan Xu: xu_fan@126.com
                Journal
                Journal ID (nlm-ta): BMC Health Serv Res
                Journal ID (iso-abbrev): BMC Health Serv Res
                Title: BMC Health Services Research
                Publisher: BioMed Central (London )
                ISSN (Electronic): 1472-6963
                Publication date (Electronic): 22 February 2024
                Publication date PMC-release: 22 February 2024
                Publication date Collection: 2024
                Volume: 24
                Electronic Location Identifier: 231
                Affiliations
                [1 ]Graduate School, Kunming Medical University, ( https://ror.org/038c3w259) No. 1168, Chunrong West Road, Yuhua Street, Chenggong District, Kunming, China
                [2 ]Department of Pharmacy, 920 Hospital of Joint Logistics Support Force, No. 212, Daguan Road, Xishan District, Kunming, China
                [3 ]The First Affiliated Hospital of Kunming Medical University, ( https://ror.org/02g01ht84) No. 295 Xichang Road, Wuhua District, Kunming, China
                Article
                Publisher ID: 10696
                DOI: 10.1186/s12913-024-10696-8
                PMC ID: 10885495
                PubMed ID: 38388389
                SO-VID: 4fff3b1a-2731-4039-be3b-8b334f39dd33
                Copyright © © The Author(s) 2024
                License:

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                Date received : 29 June 2023
                Date accepted : 8 February 2024
                Categories
                Subject: Research
                Custom metadata
                issue-copyright-statement © BioMed Central Ltd., part of Springer Nature 2024

                ScienceOpen disciplines: Health & Social care
                Keywords: pharmacy intravenous admixture services,pharmacy intravenous admixture services data reporting and analysis platform,pivas management
                Data availability:
                ScienceOpen disciplines: Health & Social care
                Keywords: pharmacy intravenous admixture services, pharmacy intravenous admixture services data reporting and analysis platform, pivas management

                Comments

                Comment on this article